ClinVar Miner

Submissions for variant NM_020451.3(SELENON):c.1379C>T (p.Ser460Phe)

dbSNP: rs767530943
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000794147 SCV000933537 uncertain significance Eichsfeld type congenital muscular dystrophy 2021-06-22 criteria provided, single submitter clinical testing This variant has been observed in individual(s) with SELENON-related disease (PMID: 30642275, 29382405). ClinVar contains an entry for this variant (Variation ID: 641007). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant is present in population databases (rs767530943, ExAC 0.002%). This sequence change replaces serine with phenylalanine at codon 460 of the SELENON protein (p.Ser460Phe). The serine residue is moderately conserved and there is a large physicochemical difference between serine and phenylalanine.
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV000794147 SCV003761211 likely pathogenic Eichsfeld type congenital muscular dystrophy 2023-01-24 criteria provided, single submitter curation The p.Ser460Phe variant in SELENON has been reported in 4 individuals with SELENON-RM (PMID: 30642275, 29382405, Munell_2018) and has been identified in 0.002% (2/111376) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs767530943). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID#: 641007) and has been interpreted as a variant of uncertain significance by Invitae. Of the 3 affected individuals, 2 of those were homozygotes and 1 was a compound heterozygote that carried a reported pathogenic variant with unknown phase, which increases the likelihood that the p.Ser460Phe variant is pathogenic (VariationID: 4496; PMID: 30642275, 29382405, Munell_2018). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive SELENON-RM. ACMG/AMP Criteria applied: PM3_strong, PP3, PM2_supporting (Richards 2015).
Revvity Omics, Revvity RCV000794147 SCV003819327 uncertain significance Eichsfeld type congenital muscular dystrophy 2019-02-26 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV004526024 SCV005040074 uncertain significance not specified 2024-03-07 criteria provided, single submitter clinical testing Variant summary: SELENON c.1379C>T (p.Ser460Phe) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8.1e-06 in 245756 control chromosomes. c.1379C>T has been reported in the literature in individuals affected with Eichsfeld Type Congenital Muscular Dystrophy. These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. ClinVar contains an entry for this variant (Variation ID: 641007). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.